Characterization and Analysis of the Skin Microbiota in Rosacea: A Case-Control Study
- PMID: 31502207
- PMCID: PMC8062047
- DOI: 10.1007/s40257-019-00471-5
Characterization and Analysis of the Skin Microbiota in Rosacea: A Case-Control Study
Abstract
Background: The efficacy of antibiotics in rosacea treatment suggests a role for microorganisms in its pathophysiology. Growing concern over the adverse effects of antibiotic use presents a need for targeted antimicrobial treatment in rosacea.
Objective: We performed a case-control study to investigate the skin microbiota in patients with rosacea compared to controls matched by age, sex, and race.
Methods: Nineteen participants with rosacea, erythematotelangiectatic, papulopustular, or both, were matched to 19 rosacea-free controls. DNA was extracted from skin swabs of the nose and bilateral cheeks of participants. Sequencing of the V3V4 region of the bacterial 16S ribosomal RNA gene was performed using Illumina MiSeq and analyzed using QIIME/MetaStats 2.0 software.
Results: Compared with controls, skin microbiota in erythematotelangiectatic rosacea was depleted in Roseomonas mucosa (p = 0.004). Papulopustular rosacea was enriched in Campylobacter ureolyticus (p = 0.001), Corynebacterium kroppenstedtii (p = 0.008), and the oral flora Prevotella intermedia (p = 0.001). The highest relative abundance of C. kroppenstedtii was observed in patients with both erythematotelangiectatic and papulopustular rosacea (19.2%), followed by papulopustular (5.06%) and erythematotelangiectatic (1.21%) rosacea. C. kroppenstedtii was also associated with more extensive disease, with the highest relative abundance in rosacea affecting both the cheeks and nose (2.82%), followed by rosacea sparing the nose (1.93%), and controls (0.19%).
Conclusions: The skin microbiota in individuals with rosacea displays changes from that of healthy skin, suggesting that further studies examining a potential role for the skin microbiota in the pathophysiology of rosacea may be warranted.
Conflict of interest statement
Figures





Similar articles
-
Comparison of the skin microbiota in acne and rosacea.Exp Dermatol. 2021 Oct;30(10):1375-1380. doi: 10.1111/exd.14098. Epub 2020 May 3. Exp Dermatol. 2021. PMID: 32278334
-
Microbiota of Demodex mites from rosacea patients and controls.Microb Pathog. 2014 Jun-Jul;71-72:37-40. doi: 10.1016/j.micpath.2014.04.002. Epub 2014 Apr 24. Microb Pathog. 2014. PMID: 24768927
-
Positive correlation between serum immunoreactivity to Demodex-associated Bacillus proteins and erythematotelangiectatic rosacea.Br J Dermatol. 2012 Nov;167(5):1032-6. doi: 10.1111/j.1365-2133.2012.11114.x. Epub 2012 Sep 25. Br J Dermatol. 2012. PMID: 22709541
-
The Use of Oral Antibiotics in the Management of Rosacea.J Drugs Dermatol. 2019 Jun 1;18(6):506. J Drugs Dermatol. 2019. PMID: 31251542 Review.
-
Skin microbiota: overview and role in the skin diseases acne vulgaris and rosacea.Future Microbiol. 2013 Feb;8(2):209-22. doi: 10.2217/fmb.12.141. Future Microbiol. 2013. PMID: 23374126 Review.
Cited by
-
Comparison of the Skin Microbiota in the Periocular Region between Patients with Inflammatory Skin Diseases and Healthy Participants: A Preliminary Study.Life (Basel). 2024 Aug 30;14(9):1091. doi: 10.3390/life14091091. Life (Basel). 2024. PMID: 39337875 Free PMC article.
-
Rosacea Treatment: Review and Update.Dermatol Ther (Heidelb). 2021 Feb;11(1):13-24. doi: 10.1007/s13555-020-00461-0. Epub 2020 Nov 10. Dermatol Ther (Heidelb). 2021. PMID: 33170491 Free PMC article. Review.
-
Microbiome-Based Products: Therapeutic Potential for Inflammatory Skin Diseases.Int J Mol Sci. 2025 Jul 14;26(14):6745. doi: 10.3390/ijms26146745. Int J Mol Sci. 2025. PMID: 40724992 Free PMC article. Review.
-
Impact of Microencapsulated Benzoyl Peroxide on the Skin Microbiome and Clinical Outcomes in Rosacea: An Update on a Randomized, Double-blind, Crossover, Vehicle-controlled Clinical Trial.J Clin Aesthet Dermatol. 2025 Aug;18(8):34-40. J Clin Aesthet Dermatol. 2025. PMID: 40843233 Free PMC article.
-
Microbiome: Role in Inflammatory Skin Diseases.J Inflamm Res. 2024 Feb 15;17:1057-1082. doi: 10.2147/JIR.S441100. eCollection 2024. J Inflamm Res. 2024. PMID: 38375021 Free PMC article. Review.
References
-
- Wilkin JK. Rosacea: pathophysiology and treatment. Arch Dermatol. 1994;130:359–62. - PubMed
-
- Powell FC. Clinical practice: rosacea. N Engl J Med. 2005;352(8):793–800. - PubMed
-
- Wilkin J, Dahl M, Detmar M, et al. Standard classification of rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2002;46(4):584–7. - PubMed
-
- Wilkin J, Dahl M, Detmar M, et al. Standard grading system for rosacea: report of the National Rosacea Society Expert Committee on the classification and staging of rosacea. J Am Acad Dermatol. 2004;50(6):907–12. - PubMed
-
- Powell FC. What’s going on in rosacea? J Eur Acad Dermatol Venereol. 2000;14:351–2. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical